Your browser doesn't support javascript.
loading
Extrapyramidal symptoms in children and adolescents treated with different dose of low potency neuroleptics
Egyptian Journal of Psychiatry [The]. 1994; 17 (2): 179-185
in En | IMEMR | ID: emr-32222
Responsible library: EMRO
Neuroleptic-induced extrapyramidal symptoms [EPS] were evaluated in 61 children and adolescents over 4 weeks of treatment. In patients treated with low potency neuroleptics, EPS was twice as common with higher doses >300 mg [60%] than with lower doses <299 mg chlorpromazine equivalents. In patients who were neuroleptic-free before initiation of drug treatment, EPS were more than 3 times as common in higher doses [73%] than in lower doses [18%]. The implications of these findings were discussed and the use of prophylactic antiparkinsonian agents in combination with higher doses of low potency neuroleptics were suggested
Subject(s)
Search on Google
Index: IMEMR Main subject: Antipsychotic Agents / Basal Ganglia Diseases Language: En Journal: Egypt. J. Psychiatry Year: 1994
Search on Google
Index: IMEMR Main subject: Antipsychotic Agents / Basal Ganglia Diseases Language: En Journal: Egypt. J. Psychiatry Year: 1994